U.S. flag

An official website of the United States government

NM_058216.3(RAD51C):c.801del (p.Gln267fs) AND Breast-ovarian cancer, familial, susceptibility to, 3

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
May 3, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001779209.2

Allele description [Variation Report for NM_058216.3(RAD51C):c.801del (p.Gln267fs)]

NM_058216.3(RAD51C):c.801del (p.Gln267fs)

Gene:
RAD51C:RAD51 paralog C [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
17q22
Genomic location:
Preferred name:
NM_058216.3(RAD51C):c.801del (p.Gln267fs)
HGVS:
  • NC_000017.11:g.58709954del
  • NG_023199.1:g.22353del
  • NM_058216.3:c.801delMANE SELECT
  • NP_478123.1:p.Gln267fs
  • LRG_314:g.22353del
  • NC_000017.10:g.56787315del
  • NM_058216.3:c.801delGMANE SELECT
  • NR_103872.2:n.676del
Protein change:
Q267fs
Links:
dbSNP: rs2143853790
NCBI 1000 Genomes Browser:
rs2143853790
Molecular consequence:
  • NM_058216.3:c.801del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NR_103872.2:n.676del - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Breast-ovarian cancer, familial, susceptibility to, 3
Synonyms:
RAD51C-Related Breast/Ovarian Cancer
Identifiers:
MONDO: MONDO:0013253; MedGen: C3150659; Orphanet: 145; OMIM: 613399

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV001623544Hereditary Cancer Group, L’Institut d'Investigació Biomèdica de Bellvitge
criteria provided, single submitter

(ACMG Guidelines, 2015)		Likely pathogenic
(May 3, 2021) 		germlinecuration

PubMed (2)
[See all records that cite these PMIDs]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedcuration

Citations

PubMed

Germline Mutation in 1338 BRCA-Negative Chinese Hereditary Breast and/or Ovarian Cancer Patients: Clinical Testing with a Multigene Test Panel.

Kwong A, Shin VY, Chen J, Cheuk IWY, Ho CYS, Au CH, Chan KKL, Ngan HYS, Chan TL, Ford JM, Ma ESK.

J Mol Diagn. 2020 Apr;22(4):544-554. doi: 10.1016/j.jmoldx.2020.01.013. Epub 2020 Feb 15.

PubMed [citation]
PMID:
32068069

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Hereditary Cancer Group, L’Institut d'Investigació Biomèdica de Bellvitge, SCV001623544.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 16, 2025